Commentary: a physiological approach to hepatic drug clearance
- PMID: 1164821
- DOI: 10.1002/cpt1975184377
Commentary: a physiological approach to hepatic drug clearance
Abstract
A physiological approach has been developed recognizing that hepatic blood flow, the activity of the overall elimination process (intrinsic clearance), drug binding in the blood, and the anatomical arrangement of the hepatic circulation are the major biological determinants of hepatic drug clearance. This approach permits quantitative prediction of both the unbound and total drug concentration/time relationships in the blood after intravenous and oral administration, and any changes that may occur as a result of alterations in the above biological parameters. These considerations have led to a classification of drug metabolism based on the hepatic extraction ratio. The proposed classification allows prediction and interpretation of the effects of individual variations in drug-metabolizing activity, route of administration, pharmacokinetic interactions, and disease states on hepatic drug elimination.
Similar articles
-
Altered hepatic blood flow and drug disposition.Clin Pharmacokinet. 1976;1(2):135-55. doi: 10.2165/00003088-197601020-00005. Clin Pharmacokinet. 1976. PMID: 13954 Review.
-
Clearance and biologic half-life as indices of intrinsic hepatic metabolism.J Pharmacol Exp Ther. 1974 Oct;191(1):17-24. J Pharmacol Exp Ther. 1974. PMID: 4423599 No abstract available.
-
[Hepatic clearance of drugs. Physiological and pharmacokinetic considerations].J Pharmacol. 1983 Apr-Jun;14(2):107-39. J Pharmacol. 1983. PMID: 6865443 French.
-
A new model-independent physiological approach to study hepatic drug clearance and its applications.Int J Clin Pharmacol Ther Toxicol. 1984 Nov;22(11):577-90. Int J Clin Pharmacol Ther Toxicol. 1984. PMID: 6389376 Review.
-
Hepatic elimination of drugs with concentration-dependent serum protein binding.J Pharmacokinet Biopharm. 1984 Feb;12(1):67-81. doi: 10.1007/BF01063611. J Pharmacokinet Biopharm. 1984. PMID: 6747819
Cited by
-
Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin.J Pharmacokinet Biopharm. 1977 Oct;5(5):495-505. doi: 10.1007/BF01061730. J Pharmacokinet Biopharm. 1977. PMID: 925883 No abstract available.
-
The plasma protein binding of basic drugs.Br J Clin Pharmacol. 1986 Nov;22(5):499-506. doi: 10.1111/j.1365-2125.1986.tb02927.x. Br J Clin Pharmacol. 1986. PMID: 3790398 Free PMC article.
-
Pharmacokinetic drug interactions with phenytoin (Part II).Clin Pharmacokinet. 1990 Feb;18(2):131-50. doi: 10.2165/00003088-199018020-00004. Clin Pharmacokinet. 1990. PMID: 2180613 Review. No abstract available.
-
Lack of efficacy of cimetidine and ranitidine as inhibitors of tolbutamide metabolism.Eur J Clin Pharmacol. 1988;34(6):653-6. doi: 10.1007/BF00615234. Eur J Clin Pharmacol. 1988. PMID: 3169118 Clinical Trial.
-
The effect of induction with phenobarbital on the kinetics and bioavailability of antipyrine in the dog.Eur J Drug Metab Pharmacokinet. 1988 Apr-Jun;13(2):123-7. doi: 10.1007/BF03191313. Eur J Drug Metab Pharmacokinet. 1988. PMID: 3208791
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources